Evidence map›Paper›PMID 25312960›Full record

ArticleInfection and immunity2015

Susceptibility to Plasmodium yoelii preerythrocytic infection in BALB/c substrains is determined at the point of hepatocyte invasion.

Alexis Kaushansky, Laura S Austin, Sebastian A Mikolajczak, Fang Y Lo, Jessica L Miller, Alyse N Douglass, Nadia Arang, Ashley M Vaughan, Malcolm J Gardner, Stefan H I Kappe

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria.Frontiers in cellular and infection microbiology · 2022
    Review
  5. Suppression of Plasmodium MIF-CD74 signaling protects against severe malaria.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  6. Review
  7. Review
  8. Review
  9. Elucidating Spatially-Resolved Changes in Host Signaling DuringFrontiers in cellular and infection microbiology · 2021
    Article
  10. Immune responses in liver and spleen againstJournal of advanced research · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alexis KaushanskySeattle Biomedical Research Institute, Seattle, Washington, USA.
Laura S AustinSeattle Biomedical Research Institute, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA.
Sebastian A MikolajczakSeattle Biomedical Research Institute, Seattle, Washington, USA.
Fang Y LoSeattle Biomedical Research Institute, Seattle, Washington, USA.
Jessica L MillerSeattle Biomedical Research Institute, Seattle, Washington, USA.
Alyse N DouglassSeattle Biomedical Research Institute, Seattle, Washington, USA.
Nadia ArangSeattle Biomedical Research Institute, Seattle, Washington, USA.
Ashley M VaughanSeattle Biomedical Research Institute, Seattle, Washington, USA.
Malcolm J GardnerSeattle Biomedical Research Institute, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA.
Stefan H I KappeSeattle Biomedical Research Institute, Seattle, Washington, USA Department of Global Health, University of Washington, Seattle, Washington, USA stefan.kappe@seattlebiomed.org.
Center for Infectious Disease Research · USUniversity of Washington · US

Funding

Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Perturbations of host cell signaling by a complex hepatotropic pathogenR01GM101183 · NIGMS · SEATTLE CHILDREN'S HOSPITAL · PI KAUSHANSKY, ALEXIS · 2013 to 2021
$3.6M
Investigating the Role of Cellular Signaling in Liver-Stage Malaria InfectionF32AI091129 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI KAUSHANSKY, ALEXIS · 2010 to 2012
$156k
NIAID NIH HHS F32 AI091129NIAID NIH HHS T32 AI007509NIAID NIH HHS T32 AI007509-13NIGMS NIH HHS 1R01GM101183-01A1NIGMS NIH HHS R01 GM101183
6 · The paper itself

Abstract

After transmission by Anopheles mosquitoes, Plasmodium sporozoites travel to the liver, infect hepatocytes, and rapidly develop as intrahepatocytic liver stages (LS). Rodent models of malaria exhibit large differences in the magnitude of liver infection, both between parasite species and between strains of mice. This has been mainly attributed to differences in innate immune responses and parasite infectivity. Here, we report that BALB/cByJ mice are more susceptible to Plasmodium yoelii preerythrocytic infection than BALB/cJ mice. This difference occurs at the level of early hepatocyte infection, but expression levels of reported host factors that are involved in infection do not correlate with susceptibility. Interestingly, BALB/cByJ hepatocytes are more frequently polyploid; thus, their susceptibility converges on the previously observed preference of sporozoites to infect polyploid hepatocytes. Gene expression analysis demonstrates hepatocyte-specific differences in mRNA abundance for numerous genes between BALB/cByJ and BALB/cJ mice, some of which encode hepatocyte surface molecules. These data suggest that a yet-unknown receptor for sporozoite infection, present at elevated levels on BALB/cByJ hepatocytes and also polyploid hepatocytes, might facilitate Plasmodium liver infection.

Indexed as

Disease SusceptibilityEndocytosisAnimalsFemaleGene Expression ProfilingHepatocytesMalariaMice, Inbred BALB CPlasmodium yoelii

Identifiers

PMID25312960
PMCPMC4288894
OpenAlexW2314856310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.